Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Interesting, a company with revenue - C$ 0.035.

<< Previous

Bullboard Posts

Next >>

Comment by GekkoInvestor19on Oct 15, 2020 10:27pm

146 Views

Post# 31726324

RE:Interesting, a company with revenue - C$ 0.035.

What is January 29th, 2021? I must admit I have stopped following the stock and have considered it a loss... even though I still own 6 figures worth of shares.

With the CEO no longer returning emails and essentially turning his back on the share holders, I assumed it was a lost cause.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?